Development of novel antibody therapy targeting tetraspanin CD81
Project/Area Number |
23590102
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Biological pharmacy
|
Research Institution | Shujitsu University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
WATANABE Masahiko 就実大学, 大学院医療薬学研究科, 教授 (00182949)
ARAI Yuji 京都府立医科大学, 医学部, 講師 (50347449)
NAGATSUKA Hitoshi 岡山大学, 大学院医歯薬学総合研究科, 教授 (70237535)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | テトラスパニン / CD81 / siRNA / モノクローナル抗体 / サンドイッチELISA / 炎症性サイトカイン / シノビオリン / TNFalpha / アポトーシス / グリア細胞 / iPS細胞 / 関節リウマチ / ELISA |
Research Abstract |
Extracellular domain of CD81 was expressed in E.coli and immunized into mice. Monoclonal antibodies against CD81 were established from these mice, and antibody treatment of RA was performed by using CIA rat model. Furthermore, quantitative sandwich ELISA system was established by using recombinant CD81 and anti-CD81 antibodies. CD81siRNA introduced into SW982 cells reduced the expression of inflammatory cytikines and synoviolin.
|
Report
(4 results)
Research Products
(17 results)
-
-
-
-
-
-
-
-
-
-
[Journal Article] Effect of risedronate on osteoblast differentiation, expression of receptor activator of NF-κB ligand and apoptosis in mesenchymalstem cells2011
Author(s)
Fujita H, Kurokawa K, Ogino T, Ono M, Yamamoto M, Oka T, Nakanishi T, kobayashi N, Tanaka N, Ogawa T, SUzaki E, Utsumi K, Sasaki J
-
Journal Title
Basic Clin Pharmacol Toxicol
Volume: 109
Pages: 78-84
Related Report
-
-
-
-
-
-
-